Indianapolis-based Eli Lilly and Co. is suing Sun Pharmaceutical Industries Ltd. of India to stop Sun from selling a generic version of its hyper-disorder drug Strattera. Lilly, which filed the suit in Detroit on Sept. 20, said it would be “irreparably harmed” if the generic wasn’t stopped, according to Bloomberg. Sun’s application to the U.S. […]
LESSONS LEARNED JENNIFER Q SMITH Queen of Fuzz, AvantGarb Have It’s hard to take Jennifer Q Smith too seriously. Oh, she’s the consummate professional, to be sure-responding to an e-mail inquiry about her company with the speed and savvy you’d expect from someone who has run her own business for 20 years. Her marketing materials are slick, her shtick smooth. Her northeast-side work space is clearly well used. But the hot pink fuzz ball that looms in the entryway (dressed…
ParaPRO LLC, a startup specialty pharmaceutical company that’s developing a novel treatment for head lice, has received a $2.1 million grant from the 21st Century Research and Technology Fund, the Indiana Economic Development Corp. announced today. The grant will allow the Carmel company to complete clinical trials of its medicine for head lice and their […]
Sales of Eli Lilly and Co.’s drugs in China are increasing at an even faster clip than the fast-growing nation’s overall pharmaceutical market, Reuters reports. Lilly’s sales are rising about 26 percent a year compared with 16 percent for the entire drug industry in China, the world’s most populous country. Lilly introduced five drugs to […]
Eli Lilly and Co.’s osteoporosis drug Evista has been approved to reduce risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer, the Indianapolis drugmaker announced today. The U.S. Food and Drug Administration move came after an FDA advisory panel in late July recommended the […]
The sliding value of the U.S. dollar is boosting financial results for some of Indiana’s big exporters. The dollar recently
hit its lowest point in 15 years against an index of other major currencies, such as the euro, the Chinese yuan and Canadian
dollar.
Jim Cornelius had such success selling Guidant Corp. last year that analysts can’t stop speculating when he’ll pull off a mega-merger at B r i s t o l – M y e r s Squibb, the firm he now leads. How about pairing it, for instance, with Eli Lilly and Co., where Cornelius used to be chief financial officer? “We’re about the same size. Both Sidney Taurel and John Lechleiter are former colleagues and good friends. You can never…
PROFILE TRINA BANNISTER Tasty treat, traditions lead to new business It all started with the sweet-potato pies. Each Thanksgiving, Trina Bannister’s grandmother Ruby would bake dozens of the sweet treats for her large extended family. Bannister and her sisters grew up learning her baking secrets. To honor her grandmother, who died about six years ago, Bannister named her new business in the Indianapolis City Market “Ruby’s Sweet Treasures.” She sells a wide variety of baked goods, from her signature pies…
Eli Lilly and Co. spent nearly $2 million in the first half of 2007 to lobby the federal government, the Associated Press reported today. The Indianapolis-based drug maker lobbied on issues related to patent reform, intellectual property, counterfeiting, prescription drug user fees, health care reform and Medicare, according to the form posted online Aug. 13 […]
Citizens Gas & Coke Utility shuttered its coke manufacturing plant earlier this summer, much to the relief of neighbors and
health officials who warned that its benzene emissions were a cancer threat. But regulatory filings show closing the plant
at Keystone Avenue and Prospect Street could result in more pollution downtown.
“Diversity” is a word that gets thrown around a lot these days. The pair of words “diversity management” might be more to the point. Diversity really is a fact of life. In terms of humankind, the world is made up of different kinds of people. And those differences go way beyond race, gender and ethnicity. People come from different backgrounds, believe in different religions, and have different sexual preferences, for example. Some are physically handicapped or mentally impaired. Our differences…
After testing a new kind of wellness program at Eli Lilly and Co., WellPoint Inc. is offering the broad program to all national employers served by its Anthem subsidiary. WellPoint touts its Healthy Lifestyles program as a help to employers trying to get their workers to make healthy behavior changes in five key areas: tobacco […]
Indianapolis-based Eli Lilly and Co. paid more money-$11 million-to Minnesota doctors, nurses and medical foundations than any other drug company between 2002 and 2004, according to the Pioneer Press of St. Paul, Minn. The report is based on Minnesota’s strict disclosure law. Only Maine and Vermont have similar laws requiring pharmaceutical companies to open books […]
Terry Majors wants to make a name for himself in the business community, and he’s confident he’s well on his way to being successful. Making eye contact, he shakes hands firmly and confidently. He’s dressed neatly and professionally in a white, buttondown shirt and tie. His shoes are well-polished. He speaks in a friendly, yet authoritative, voice about a new job he will soon start. “It’s all about choices,” he says philosophically of life, as if he’s been making choices…
Wanted: Corporate types willing to give an hour of time a week to a cause that is as critical as any business decision ever made. Must be willing to work with children. If interested, contact the United Way of Central Indiana. Intrigued? Then you might be a candidate for the ReadUP program, which aims to help fourth-graders within the Indianapolis Public Schools system become better readers. The ultimate goal is to produce more high school graduates for a district in…
A psychiatrist who advises the state of Minnesota on which drugs to use in Medicaid programs received $488,953 in speaking fees from Indianapolis-based Eli Lilly and Co. over eight years through 2006, according to an Associated Press analysis. The fees, received by John E. Simon, have raised questions about whether Simon was influenced to recommend […]
Eli Lilly and Co.’s depression drug Cymbalta dampened pain in patients with fibromyalgia and has asked the Food and Drug Administration to approve it for secondary use, the Indianapolis pharmaceutical maker said today. Patients experienced less pain beginning a week after taking the treatment, a study showed. Two percent to 4 percent of Americans, mostly […]
In the less than two years since Mark Miles, 53, took over the CEO-driven Central Indiana Corporate Partnership in 2006, he’s
transformed it into an economic development powerhouse for life sciences, information technology and advanced manufacturing.
How so fast? He started networking with Indiana’s political heavyweights more than 30 years ago. And he never stopped.
Downtown and suburban vacancy rates are declining slightly or at least holding steady-a positive sign for an Indianapolis office market absorbing a plethora of new space on the city’s north side. The second-quarter vacancy rate for the central business district dropped to 15.9 percent, from 16.7 percent the previous quarter, according to data from the local office of St. Louis-based commercial real estate firm Colliers Turley Martin Tucker. A similar report from the local office of Los Angeles-based CB Richard…
Local hospitality firm’s early work with Lilly helped it carve out a major niche in the pharmaceutical market.
